141 |
Impacto do exercício físico na hiperalgesia induzida pela administração repetida de morfina em ratos neonatosNunes, Éllen Almeida January 2016 (has links)
A morfina é um analgésico eficaz e muitas vezes opioide usado para aliviar a dor moderada a grave durante o período neonatal precoce. A exposição repetida de morfina no início da vida tem implicações duradouras para o desenvolvimento do sistema nervoso, tais como alterações neuroquímicas e comportamentais a longo prazo em ratos. O exercício físico vem sendo utilizado como uma alternativa não farmacológica para tratamento de quadros dolorosos. Deste modo nosso objetivo foi avaliar o efeito da exposição a morfina no período neonatal nas respostas nociceptiva (térmica e mecânica) e bioquímicas (citocinas e neurotrofinas) em ratos de P30 e P60 antes e após a exposição ao exercício físico. Ratos Wistar com 7 dias foram divididos em dois grupos: salina (SA) e morfina (MO) e submetidos a 5 mg / dia / 7 dias P8 para P14 a soro fisiológico ou MO respectivamente. Nas idades de P16, P30 e P60 a resposta nociceptiva térmica foi avaliada através do teste da placa quente (PQ), a resposta mecânica por Von Frey (VF) e Randal e Selitto (RS). Ainda foram medidos os níveis basais de BDNF, NGF, IL-6 e IL-10 em córtex cerebral e tronco encefálico. Após a sessão de exercício foram realizados em P30 e P60 o teste de PQ, 1h e 24h após o exercício, o teste de VF foi realizado 24h após e os níveis de BDNF, NGF, IL-6 e IL-10 também foram medidos em córtex cerebral e tronco encefálico após a exposição ao exercício. Nossos resultados demonstram que os animais que receberam morfina no período neonatal apresentam diminuição do limiar nociceptivo térmico e mecânico em P30 e P60. Os níveis de BDNF, NGF, IL-6 e IL-10 apresentaram relação direta com a idade em tronco encefálico, aumento ao longo do tempo. Em córtex cerebral os níveis de BDNF e NGF demonstraram uma interação entre os fatores grupo e idade, onde os animais do grupo MO têm diminuição desses com a idade. A IL-10 teve efeito somente da idade, enquando a IL-6 não se mostrou alterada por nenhum fator. Após a exposição ao exercício no teste da PQ no P30 e P60 os animais SAE tiveram uma diminuição do limiar nociceptivo se igualando aos grupos que receberam morfina. No teste de VF em P30 os grupos que receberam morfina são diferentes do grupos salina. Em P60 o grupo SAE mostra mais uma vez diminuiçao do limiar nociceptivo se igualando as grupos morfina. Nos níveis de BDNF e NGF em tronco encefálico ocorreu interação entre idade e grupo, onde o grupo MOE demonstra diminuição. Em tronco encefalico a IL-6 e Il-10 só tiveram efeito da idade. Em córtex cerebral os níveis de BDNF tiveram interação entre idade e grupo, o grupo MOE teve diminuição destes níveis em comparação aos demais grupos. Nos níveis de NGF se observou efeito do tempo e do grupo onde os grupos que recebem morfina têm níveis menores do que os que recebem salina em P60. O grupo MOS teve níveis menores de IL-6 em cortex cerebral do que os demais grupos, enquanto que os níveis de IL-10 só tiveram efeito da idade. Portanto a morfina no período neonatal leva a diminuição no limiar nociceptivo térmico e mecânico em ratos e que o exercício físico melhora os níveis BDNF, NGF e IL-6 em animais expostos a morfina no período neonatal. Porém o exercício físico não foi capaz de reverter a hiperalgesia e alodínia induzida pela morfina nos animais de P30 e P60. Sendo assim nossos dados mostram a necessidade de mais estudos sobre a dor em recém-nascidos e o sobre o uso de opioides neste período. Também se mostra necessário mais estudos sobre tratamentos não farmacológicos como o exercício físico. / Morphine is an effective analgesic often used to relieve moderate to severe pain during the early neonatal period. In our previous study, repeated morphine exposure in early life triggered persistent implications for the development of the nervous system, such as neurochemical and behavioral alterations in rats at long-term. The exercise has been used as a non-pharmacological alternative for treating painful conditions. Thus our aim was to evaluate the effect of repeated morphine exposure during the neonatal period upon nociceptive responses (thermal and mechanical) and biochemical markers (cytokines and neurotrophins) before and after unique physical exercise session in rats at P30 and P60. Seven-day-old male Wistar rats were divided into two groups: saline and morphine and subjected to saline and morphine (5 μg/day/7 days) from P8 to P14, respectively. At P16, P30 and P60, the thermal nociceptive response was assessed using the hot plate test (HP), while the mechanical response by Von Frey (VF) and Randal and Selitto (RS) tests. The basal levels of BDNF, NGF, IL-6 and IL-10 were measured in brainstem and cerebral cortex. One hour and 24h after exercise, the HP was conducted in P30 and P60, the VF test was only performed 24 ho after exercise, as well as the levels of BDNF, NGF, IL-6 and IL-10 were also measured in cerebral cortex and brainstem. Our results show that rats that received morphine in the neonatal period presented decreased thermal and mechanical nociceptive threshold in P30 and P60. And, BDNF, NGF, IL-6 and IL-10 levels presented a direct relationship with age in brainstem, increase their levels when the age increased. In cerebral cortex, BDNF and NGF levels showed an interaction between age and treatment group, where the morphine group showed decreased levels when the age increased. There was age effect upon IL-10 levels and no effects upon IL-6 levels in cerebral cortex. After 24h of exercise, saline group subjected to exercise presented decreased nociceptive threshold in using HP at P30 and P60, with similar threshold presented by morphine group. In VF test, both morphine groups presented decreased threshold in relation to both saline groups at P30. However, at P60, saline group subjected to exercise presented decreased nociceptive threshold, matching the morphine groups. In brainstem, we found interaction between age and group in BDNF and NGF levels, where morphine-exercise group showed decreased levels; and we observed only age effect upon IL-6 and IL-10 levels. In cerebral cortex, we observed interaction between age and group upon BDNF levels, where morphine-exercise group showed decreased levels compared to other groups. In relation to NGF levels, we observed effect of age and group, where morphine groups presented lower levels than saline groups in P60. The morphine-sedentary group presented lower IL-6 levels in the cerebral cortex than the other groups, while only age effect was observed on IL-10 levels. Our data lead us to conclude that morphine exposure in the neonatal period triggers a decrease in thermal nociceptive and mechanical thresholds in rats. And, the physical exercise improves BDNF, NGF and IL-6 levels in rats exposed to morphine in the neonatal period. However, on session of exercise was not able to revert the hyperalgesia and allodynia induced by morphine in rats at P30 and P60. Therefore, our data highlight the need of more studies about pain in newborns and neonates and the effect of the opioid use in this period. And, it is necessary more studies about non-pharmacological treatments, for example exercise.
|
142 |
Marcadores inflamatórios no comprometimento cognitivo leve amnéstico : estudo caso-controleRizzi, Liara January 2014 (has links)
Introdução: A Doença de Alzheimer (DA) é uma desordem neurodegenerativa e a forma mais comum de demência. Processos inflamatórios parecem desempenhar importante papel na fisiopatologia da DA. A neuroinflamação é caracterizada pela ativação da microglia e a liberação de citocinas inflamatórias, tais como IL-1β, IL-6 e TNF-α. Porém, não se sabe qual é a real contribuição destes marcadores inflamatórios no desenvolvimento da DA. Objetivos: A proposta deste estudo é avaliar a possível relação entre marcadores inflamatórios no liquido cefalorraquidiano de indivíduos com comprometimento cognitivo leve amnéstico (CCL-a), com 60 anos ou mais, e comparar com controles saudáveis da mesma faixa etária. Métodos: Foram examinadas as concentrações de IL-1β, IL-6 e TNF-α no líquido cefalorraquidiano de sujeitos com CCL-a e em controles pelo método ELISA. Diagnósticos de CCL-a foram baseados na anamnese e nos critérios de Petersen, corroborados pela escala CDR. Para avaliar a função cognitiva o teste de memória e reconhecimento de palavras do CERAD e o Teste do Relógio foram aplicados aos participantes. Para a avaliação de sintomas depressivos usou-se o GDS. Resultados: Este estudo demonstrou diminuição significativa nos níveis de IL-1β (13.735 vs 22.932 pg/mL; p <0.001) e TNF-α (1.913 vs 2.627 pg/mL; p: 0.002), mas não nos níveis da IL-6 (4.178 vs 5.689 pg/mL; p: 0.106), entre casos e controles. Indivíduos com IL-1β < 17 pg/mL possuem 7.2 (CI: 1.5-36; p: 0.016) mais chances de evoluírem à CCL-a. Além disso, houve correlação positiva entre IL-1β e a pontuação da lista de palavras do CERAD (rs: 0.299; p: 0.046). A análise de regressão linear mostrou que os níveis de IL-1β podem explicar 13.7% (β: 24.545; p: 0.012) da variância da pontuação do CERAD, o que sugere uma dependência linear direta. Conclusões: A neuroinflamação, mediada pela IL-1β e pelo TNF-α, provavelmente possui importante papel na prevenção de CCL-a. / Introduction: Alzheimer Disease (AD) is a neurodegenerative disorder and the most common form of dementia. Inflammatory processes may play a significant role at the pathophysiology of AD. Neuroinflammation is characterized by activation of microglia and the release of inflammatory cytokines, such as IL-1β, IL-6 and TNF-α. Although, it is unknown what is the real contribution of these inflammatory markers in the development of AD. Aims: The purpose of this study is to assess the possibly relationship between inflammatory markers in CSF of amnestic MCI subjects, with sixty years or older, and compare to aged healthy controls. Methods: We examined concentrations of IL-1β, IL-6 and TNF-α at CSF of amnestic MCI subjects and controls by ELISA. MCI diagnoses were based on anamnesis and Petersen criteria, corroborated by CDR. To assess the cognitive function the word list memory test and word recognition of CERAD and Clock Drawing Test were applied to subjects, and to evaluated depression symptoms the GDS was used. Results: This study demonstrated significant diminish in the levels of IL-1β (13.735 vs 22.932 pg/mL; p <0.001) and TNF-α (1.913 vs 2.627 pg/mL; p: 0.002), but not IL-6 (1.913 vs 2.627 pg/mL; p: 0.002), between cases and controls. Individuals with IL-1β < 17 pg/mL were at a 7.2 (CI: 1.5-36; p: 0.016) increased odds of aMCI. Furthermore, there was a positive correlation between IL-1β and the CERAD word list score (rs: 0.299; p: 0.046). The linear regression analysis showed that IL-1β levels can explain 13.7% (β: 24.545; p: 0.012) of the variance on this CERAD subscore, suggesting a direct linear dependence. Conclusion: Neuroinflamation mediated by IL-1β and TNF-α may play an important role in preventing aMCI.
|
143 |
Marcadores inflamatórios no comprometimento cognitivo leve amnéstico : estudo caso-controleRizzi, Liara January 2014 (has links)
Introdução: A Doença de Alzheimer (DA) é uma desordem neurodegenerativa e a forma mais comum de demência. Processos inflamatórios parecem desempenhar importante papel na fisiopatologia da DA. A neuroinflamação é caracterizada pela ativação da microglia e a liberação de citocinas inflamatórias, tais como IL-1β, IL-6 e TNF-α. Porém, não se sabe qual é a real contribuição destes marcadores inflamatórios no desenvolvimento da DA. Objetivos: A proposta deste estudo é avaliar a possível relação entre marcadores inflamatórios no liquido cefalorraquidiano de indivíduos com comprometimento cognitivo leve amnéstico (CCL-a), com 60 anos ou mais, e comparar com controles saudáveis da mesma faixa etária. Métodos: Foram examinadas as concentrações de IL-1β, IL-6 e TNF-α no líquido cefalorraquidiano de sujeitos com CCL-a e em controles pelo método ELISA. Diagnósticos de CCL-a foram baseados na anamnese e nos critérios de Petersen, corroborados pela escala CDR. Para avaliar a função cognitiva o teste de memória e reconhecimento de palavras do CERAD e o Teste do Relógio foram aplicados aos participantes. Para a avaliação de sintomas depressivos usou-se o GDS. Resultados: Este estudo demonstrou diminuição significativa nos níveis de IL-1β (13.735 vs 22.932 pg/mL; p <0.001) e TNF-α (1.913 vs 2.627 pg/mL; p: 0.002), mas não nos níveis da IL-6 (4.178 vs 5.689 pg/mL; p: 0.106), entre casos e controles. Indivíduos com IL-1β < 17 pg/mL possuem 7.2 (CI: 1.5-36; p: 0.016) mais chances de evoluírem à CCL-a. Além disso, houve correlação positiva entre IL-1β e a pontuação da lista de palavras do CERAD (rs: 0.299; p: 0.046). A análise de regressão linear mostrou que os níveis de IL-1β podem explicar 13.7% (β: 24.545; p: 0.012) da variância da pontuação do CERAD, o que sugere uma dependência linear direta. Conclusões: A neuroinflamação, mediada pela IL-1β e pelo TNF-α, provavelmente possui importante papel na prevenção de CCL-a. / Introduction: Alzheimer Disease (AD) is a neurodegenerative disorder and the most common form of dementia. Inflammatory processes may play a significant role at the pathophysiology of AD. Neuroinflammation is characterized by activation of microglia and the release of inflammatory cytokines, such as IL-1β, IL-6 and TNF-α. Although, it is unknown what is the real contribution of these inflammatory markers in the development of AD. Aims: The purpose of this study is to assess the possibly relationship between inflammatory markers in CSF of amnestic MCI subjects, with sixty years or older, and compare to aged healthy controls. Methods: We examined concentrations of IL-1β, IL-6 and TNF-α at CSF of amnestic MCI subjects and controls by ELISA. MCI diagnoses were based on anamnesis and Petersen criteria, corroborated by CDR. To assess the cognitive function the word list memory test and word recognition of CERAD and Clock Drawing Test were applied to subjects, and to evaluated depression symptoms the GDS was used. Results: This study demonstrated significant diminish in the levels of IL-1β (13.735 vs 22.932 pg/mL; p <0.001) and TNF-α (1.913 vs 2.627 pg/mL; p: 0.002), but not IL-6 (1.913 vs 2.627 pg/mL; p: 0.002), between cases and controls. Individuals with IL-1β < 17 pg/mL were at a 7.2 (CI: 1.5-36; p: 0.016) increased odds of aMCI. Furthermore, there was a positive correlation between IL-1β and the CERAD word list score (rs: 0.299; p: 0.046). The linear regression analysis showed that IL-1β levels can explain 13.7% (β: 24.545; p: 0.012) of the variance on this CERAD subscore, suggesting a direct linear dependence. Conclusion: Neuroinflamation mediated by IL-1β and TNF-α may play an important role in preventing aMCI.
|
144 |
Perfil de citocinas pró- e anti-inflamatória e da proteína c-reativa no tratamento do tumor venéreo transmissível canino / Pro- and anti-inflammatory cytokines and c-reactive protein profiles during the treatment of canine transmissible venereal tumorStumpf, Ana Rita Lancini 28 February 2014 (has links)
The canine transmissible venereal tumor (CTVT) is unique in various
aspects, and the
principal is that the tumoral cells are not originated from the hos
t. Recent findings showed that
the CTVT is a transplantable tumor that first appeared in a
dog ancestor approximately 10000
years ago. The tumoral cells propagate mainly through coitus, develop a
s a graft, and have the
capability of installing themselves by mechanisms of escape
from the host's immunologic
response. This specific response involves cellular and humoral immunity
and varies according to
some factors not yet very elucidated. Beyond the well-known role of fi
ghting the tumor cells, the
inflammatory response also plays an involuntary and paradoxical role, w
hich results in the
promotion of tumor growth by releasing vasculogenic, antiapoptotic, and
cellular growth-
promoting substances. The fact that tumors can benefit from the inf
lammatory response makes
the investigation of the mechanisms involved important for the development
of new therapies
focused on the modulation of the inflammatory response to control the tumor
development. The
aim of this work is to better understand the mechanisms behind tumora
l growth by the
measurement of the levels of pro-inflammatory (IL-1, IL-6, TNF-
α
and INF-
γ
) and anti-
inflammatory (IL-10) cytokines and the C-reactive protein (CRP) ove
r the treatment of dogs
naturally infected with CTVT. The quantification of the cytokines and
CRP was performed in the
animals' serum from samples obtained at the moments of the diagnosis
and pre-therapy, immediately before chemotherapy, and after the confirmation of
the cure of each animal.
According to therapy response, two groups were identified, R, were t
he tumor was resistant to
therapy and NR, which was susceptible. A cure probability was define
d in relation to time of
treatment and tumor response to vincristin. In group R all parameter
s varied significantly: The
expression of pro-inflammatory cytokines and CRP were higher, and of I
L-10, lower, comparing
to group NR. For pro-inflammatory cytokines, this difference was ma
intained until cure.
Statistical analysis was able to detect correlations betwee
n all variables, demonstrating the
participation of cytokines during tumor evolution. The role of inflammati
on has been postulated
and, although the mechanisms remain unclear, a correlation of chronic i
nflammation and cancer
susceptibility has been demonstrated. Because CTVT is a tumor of
foreign cells, it is a suitable
model to investigate the mechanisms involved in tumor maintenance and deve
loping, as well as
the associated immune response. / O tumor venéreo transmissível canino (TVTc) é um tumor único em vários aspectos,
sendo o principal, o fato de as células tumorais não serem originárias do animal acometido.
Resultados de pesquisas recentes demonstraram que o TVTc é um tumor transplantável que
surgiu em ancestrais do cão doméstico há aproximadamente 10000 anos. As células, que se
propagam principalmente pelo coito, se desenvolvem como um enxerto e apresentam a
capacidade de se implantar através de mecanismos de escape à resposta imunológica do
hospedeiro. Essa resposta envolve a imunidade celular e humoral e varia de acordo com fatores
não totalmente elucidados. Além do conhecido papel na resposta imune com o objetivo de
combater tumores, a resposta inflamatória desempenha um papel involuntário e paradoxal que
resulta na promoção do crescimento tumoral pela liberação de substâncias vasculogênicas, antiapoptóticas
e promotoras de crescimento celular. O fato de que os tumores possam se beneficiar
da resposta inflamatória torna necessárias pesquisas visando o desenvolvimento de terapias
direcionadas à modulação da resposta inflamatória para o controle do desenvolvimento tumoral.
Dessa forma, o objetivo deste estudo foi compreender melhor os mecanismos envolvidos no
desenvolvimento do tumor através da mensuração dos níveis das citocinas pró-inflamatórias (IL-
1, IL-6, TNF-α e INF-γ) e da anti-inflamatória (IL-10) e de uma proteína de fase aguda da
inflamação, a Proteína C-reativa (PCR) durante o tratamento de cães naturalmente infectados
pelo TVTc. A quantificação das citocinas e da PCR foi realizada no soro dos animais a partir de
amostras obtidas no diagnóstico e pré-terapia, imediatamente antes de cada nova aplicação
9
quimioterápica e no momento em que o animal era considerado curado. A partir da resposta à
quimioterapia foram caracterizados grupos de animais de acordo com os tumores resistentes (R) e
não-resistentes (NR). Foi estabelecida a probabilidade de cura em relação ao tempo de terapia, de
acordo com o tipo de tumor. No grupo R, foi observada variação significativa em todos os
parâmetros, sendo a expressão das citocinas pró-inflamatórias e da PCR, mais elevadas e a
expressão da IL-10 inferior em relação à expressão observada em amostras dos animais do grupo
NR. No caso das citocinas pró-inflamatórias e da PCR, essa diferença se manteve até a cura dos
animais, diferindo da IL-10, cujas concentrações foram similares nos dois grupos ao final do
tratamento. A análise estatística realizada detectou a presença de correlações entre as variáveis,
demonstrando a participação das citocinas durante o processo de evolução tumoral. O papel da
inflamação no desenvolvimento do câncer foi postulado, apesar de os mecanismos moleculares
não terem sido elucidados, sabe-se que a inflamação crônica eleva a probabilidade do
desenvolvimento de tumores. Pelo fato de o TVTc ser um tumor de células estranhas ao
organismo, seu estudo é importante para verificar os mecanismos relacionados com a manutenção
e desenvolvimento dos tumores, bem como da resposta imune associada.
|
145 |
Rôle de l'apolipoprotéine E dans l'inflammation sous-rétinienne impliquée dans la Dégénérescence Maculaire Liée à l'Age / Role of apolipoprotein E in subretinal inflammation involved in Age-related Macular DegenerationLevy, Olivier 23 January 2014 (has links)
La Dégénérescence Maculaire Liée à l'Age (DMLA) constitue dans les pays industrialisés la 1ère cause de cécité chez les personnes de plus de 50 ans, et représente un enjeu majeur de santé publique d'autant plus important que le vieillissement de la population ne fait que s'accroître. La forme atrophique de cette maladie, pour laquelle il n'existe actuellement aucun traitement, est notamment caractérisée par une inflammation sous-rétinienne associée une dégénérescence des photorécepteurs, et conduit à une perte progressive de la vision centrale pouvant aller jusqu'à la cécité. Nos résultats montrent qu'au stade précoce de la maladie (MLA) on peut déjà observer de nombreux phagocytes mononucléaires (PM) dans l'espace sous-rétinien, en contact avec les drusen. Ces PM expriment de l'apolipoprotéine E (APOE), protéine impliquée dans l'homéostasie lipidique et la régulation de réponses inflammatoires, qui est retrouvée dans les drusen des patients atteints de DMLA, et dont le variant génétique APOε2 est associé à un risque élevé de développer une DMLA. Grâce à l'utilisation de souris Cx3cr1GFP/GFP déficientes en CX3CR1, un récepteur de chimiokine, et de souris humanisées APOε2, les travaux présentés ici démontrent que l'APOE exerce un rôle pro-inflammatoire conduisant de manière dose-dépendante à une altération du privilège immun sous-rétinien. Cet environnement immunosuppresseur est dépendant du FasL exprimé par l'épithélium pigmentaire rétinien (EPR), et empêche en condition physiologique la présence de cellules inflammatoires dans la rétine externe. Nos résultats montrent que l’APOE stimule de manière autocrine la sécrétion d’IL-6 par les PM, possiblement par un mécanisme impliquant une activation des Toll-like receptors (TLR) et de leur corécepteur CD36. Nous montrons que l’IL-6 inhibe l’expression de FasL sur l’EPR et altère sa capacité de clairance sous-rétinienne, ce qui facilite la survie des PM infiltrants au contact des photorécepteurs. La persistance de cette inflammation pathologique dans la rétine externe conduit au cours du vieillissement à une dégénérescence des photorécepteurs, phénomène qui peut est inhibé chez des souris déficientes en APOE. Ensemble, ces résultats permettent d’apporter une explication inédite au risque élevé de développer une DMLA pour les porteurs de l’allèle APOε2, et pourrait ouvrir la voie vers de nouvelles perspectives thérapeutiques. / Age-related Macular Degeneration (AMD) is the first cause of blindness in people over 50 year old in industrialized countries, and represents a major public health concern as the population of elderly is more and more increasing. The atrophic form of the disease, for which there is currently no treatment available, is characterized by subretinal inflammation associated with photoreceptor degeneration and leads to a progressive loss of central vision that can lead to blindness. Our results show many mononuclear phagocytes (MP) are already present at the early stage of the disease (MLA), in the subretinal space and in apposition with drusen. These PM express apolipoprotein E (APOE), a protein involved in lipid homeostasis and the regulation of inflammatory responses, which is found in drusen in patients with AMD, and whose genetic APOε2 variant is associated with a high risk of developing AMD. Using Cx3cr1GFP/GFP mice (deficient in CX3CR1, a chemokine receptor) and humanized APOε2 mice, the work presented herein demonstrates that APOE exerts a pro-inflammatory role leading to a dose-dependent alteration of the subretinal immune privilege. This immunosuppressive environment is dependent upon FasL expression by the retinal pigment epithelium (RPE), and prevents in physiological condition the presence of inflammatory cells in the outer retina. Our results show that APOE stimulates in an autocrine fashion the secretion of IL -6 by PM, possibly through a mechanism involving activation of Toll- like receptors (TLR) and their coreceptor CD36. We show that IL-6 inhibits the expression of FasL on the RPE and impairs its subretinal clearance capacity, which facilitates the survival of infiltrating PM in contact with photoreceptors. The persistence of a pathological inflammation in the outer retina leads to age-dependent photoreceptor degeneration, which can be inhibited in APOE-deficient mice. Taken together, these results provide novel rationale for the higher risk of developing AMD for APOε2allele carriers, and could allow the emergence of new therapeutic perspectives.
|
146 |
The role of interleukin-1 receptors in brain cell signallingNguyen, Loan January 2010 (has links)
IL-1α and IL-1β are two IL-1 agonists which signals at the same receptor complex composed of IL-1R1/IL-1RAcP. However, IL-1α and IL-1β exert differential actions. A recent CNS-specific IL-1 receptor accessory protein, called IL-1RAcPb, has been characterised but its actions are unknown. In T cell line, over expression of IL-1RAcPb negatively regulate IL-1 action (Smith et al, 2009), but over-expression of IL-1RAcPb in HEK cell line induces IL-1 signaling (Lu et al, 2008). The role of IL-1RAcPb has not been studied in primary cells. The aim of this project was to investigate the role of IL-1RAcPb in IL-1-induced actions in neurones and glia, and to determine IL-1α and IL-1β differential actions in these two cell types. The role of IL-1RAcPb in IL-1-induced protein expression and IL 1α and IL-1β differential effects were investigated by treating WT and IL 1RAcPb-/- neurones and glia with IL-1α or IL-1β in the presence or absence of IL-1RA for 24 h followed by assessment of IL-6 induction by ELISA. The mechanism of IL-1RAcPb actions were studied by examining the effects of IL-1α or IL-1β on p38, ERK1/2 and Src kinase activation in neurones and glia by Western blot analysis. SB203580 (p38 inhibitor), UO126 (ERK1/2 inhibitor), and PP2 (Src kinase inhibitor) were used to determine the contribution of p38, ERK1/2 and Src kinase activation to IL-1-induced IL-6 synthesis in neuronal cultures. In WT neurones, IL-1α and IL-1β were equipotent at inducing IL-6 synthesis and p38 activation, whilst both ligands failed to induce ERK1/2 or Src kinase activation. In IL-1RAcPb-/- neurones, IL-1α and IL-1β induced similar levels of IL-6, but IL-1β was more potent than IL-1α at inducing p38 activation. IL-1α-induced p38 activation was reduced in IL-1RAcPb-/- neurones compared to WT neurones. In contrast to WT neurones, ERK1/2 was activated in IL-1RAcPb-/- neurones in response to IL-1α, whilst Src kinase was not activated by IL-1α or IL 1β. IL-1-induced IL-6 synthesis was abolished by IL-1RA, SB203580, UO126 and PP2. Interestingly PP2, a specific Src kinase inhibitor also partially inhibited basal ERK1/2 activity. In WT glial cells, IL-1α was more potent than IL-1β at inducing IL-6 synthesis but both cytokines induced ERK1/2 activation with equal potency. In IL-1RAcPb-/- glia, IL-1α and IL-1β were equally potent at inducing IL-6 synthesis and ERK1/2 activation. However, IL-α-induced-IL-6 synthesis was reduced in IL 1RAcPb-/- glia compared to WT glia. In both WT and IL-1RAcPb-/- glia, IL-1α and IL-1β induced p38 activation but not Src kinase activation . In conclusion, this study showed that in neurones, IL-1RAcPb may contribute to IL-1α-induced p38 activation but negatively regulates IL-1-induced ERK1/2 activation, therefore IL-1RAcPb may have specific effects on different signalling pathways. The effect of IL-1RAcPb could also be cell specific, as IL 1RAcPb contributed to IL-1α-induced p38 signalling in neurones but IL-6 production in glia. The role of IL-1RAcPb remains largely unknown and more investigations are required to elucidate its role in IL-1 signalling in the brain.
|
147 |
L’étude du rôle de l’interleukine 6 dans le métabolisme lipidique de la cardiomyopathie diabétiqueYahi, Ourdia 03 1900 (has links)
No description available.
|
148 |
Zytokine als prognostische Faktoren beim kindlichen HydrocephalusPauer, Anke 18 March 2013 (has links)
Wir untersuchten Liquor- und Serumproben von 40 an einem shuntversorgten Hydrocephalus erkrankten Kindern auf die Konzentration der Zytokine bFGF, TGF-β1, VEGF, IL-6, IGF-1 und Leptin sowie deren Korrelation mit dem Risiko von Shuntinsuffizienzen.
Dabei konnten wir die Hypothese bestätigen, dass erhöhte Konzentration der fibrogenen Zytokine bFGF und TGF-β1 im Serum bzw. Liquor mit einem erhöhten Risiko für operationspflichtige Shuntinsuffizienzen durch Obstruktion des Schlauchsystems einhergehen, und dass diese Komplikationen mit steigenden Zytokinkonzentrationen umso eher eintreten. Außerdem war bFGF im Liquor von Kindern, die zum Abnahmezeitpunkt an einer Shuntdysfunktion durch Obstruktion oder Einwachsen des Shunts litten, signifikant höher als bei Kindern, die zum Zeitpunkt der Abnahme keine Shuntdysfunktion aus eben genannten Gründen hatten.
Des Weiteren fanden wir Konzentrationsunterschiede für IL-6 im Liquor zwischen den einzelnen Ursachen der Erkrankung, wobei das Zytokin am höchsten bei Tumorpatienten war, gefolgt von posthämorrhagischem und postmeningitischem Hydrocephalus, und am niedrigsten bei Kindern mit kongenitaler ZNS-Fehlbildung.
|
149 |
Enhanced Effects of Cigarette Smoke Extract on Inflammatory Cytokine Expression in IL-1β-Activated Human Mast Cells Were Inhibited by Baicalein via Regulation of the NF-κB PathwayChi, David S., Lin, Ta Chang, Hall, Kenton, Ha, Tuanzhu, Li, Chuanfu, Wu, Zong D., Soike, Thomas, Krishnaswamy, Guha 06 February 2012 (has links)
Background: Human mast cells are capable of a wide variety of inflammatory responses and play a vital role in the pathogenesis of inflammatory diseases such as allergy, asthma, and atherosclerosis. We have reported that cigarette smoke extract (CSE) significantly increased IL-6 and IL-8 production in IL-1β-activated human mast cell line (HMC-1). Baicalein (BAI) has anti-inflammatory properties and inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from HMC-1. The goal of the present study was to examine the effect of BAI on IL-6 and IL-8 production from CSE-treated and IL-1β-activated HMC-1.Methods: Main-stream (Ms) and Side-stream (Ss) cigarette smoke were collected onto fiber filters and extracted in RPMI-1640 medium. Two ml of HMC-1 at 1 × 10 6 cells/mL were cultured with CSE in the presence or absence of IL-1β (10 ng/mL) for 24 hrs. A group of HMC-1 cells stimulated with both IL-1β (10 ng/ml) and CSE was also treated with BAI. The expression of IL-6 and IL-8 was assessed by ELISA and RT-PCR. NF-κB activation was measured by electrophoretic mobility shift assay (EMSA) and IκBα degradation by Western blot.Results: Both Ms and Ss CSE significantly increased IL-6 and IL-8 production (p < 0.001) in IL-1β-activated HMC-1. CSE increased NF-κB activation and decreased cytoplasmic IκBα proteins in IL-1β-activated HMC-1. BAI (1.8 to 30 μM) significantly inhibited production of IL-6 and IL-8 in a dose-dependent manner in IL-1β-activated HMC-1 with the optimal inhibition concentration at 30 μM, which also significantly inhibited the enhancing effect of CSE on IL-6 and IL-8 production in IL-1β-activated HMC-1. BAI inhibited NF-κB activation and increased cytoplasmic IκBα proteins in CSE-treated and IL-1β-activated HMC-1.Conclusions: Our results showed that CSE significantly increased inflammatory cytokines IL-6 and IL-8 production in IL-1β-activated HMC-1. It may partially explain why cigarette smoke contributes to lung and cardiovascular diseases. BAI inhibited the production of inflammatory cytokines through inhibition of NF-κB activation and IκBα phosphorylation and degradation. This inhibitory effect of BAI on the expression of inflammatory cytokines induced by CSE suggests its usefulness in the development of novel anti-inflammatory therapies.
|
150 |
THE ROLE OF GP130 CYTOKINES IL-6 AND OSM ON TUMOR DEVELOPMENT IN MOUSE MODELS FOR LUNG ADENOCARCINOMALauber, Sean 10 1900 (has links)
<p>Lung cancer is the leading cause of cancer related deaths in both the US and Canada and efforts still need to be made towards understanding the disease. The role of inflammation in the promotion of cancer development represents a newer avenue of research. The glycoprotein (gp)-130 cytokine interleukin-6 (IL-6) has a well established role in promoting inflammation and recent evidence suggests roles in development of certain tumors in animal models. Less is known of the related family member oncostatin M (OSM) and the functions of either IL-6 or OSM in lung cancer development is not known. Based on the hypothesis that these cytokines promote lung cancer development, IL-6 and OSM were overexpressed in the lungs of two separate mouse models for lung cancer utilizing adenovirus vectors encoding IL-6 or OSM. The first mouse model utilized a Cre-conditional oncogene KRAS G12D (developed by Tyler Jacks) in which endotracheal administration of adenovirus (Ad)-encoded Cre-recombinase resulted in increases in lung densities in a dose-dependent fashion over a period of 6 weeks that were measurable by CT scanning and histology. Increases in cytokines IL-6 and kertinocyte chemoattractant (KC) were detectable in the bronchoalveolar lavage (BAL) by week 4, as well as marked increases in alveolar macrophage numbers. Macrophages were also shown as a possible target for Cre-mediated recombination and mutant KRAS expression. Administration of either AdIL-6 or AdOSM as well as AdCre resulted in a trend toward increases in tumor burden with AdOSM based on experiments terminated at 4 weeks. The second mouse model involved endotracheal administration of the lewis lung carcinoma (LLC) cell line, which after 7 days resulted in detectable tumor burden. Administration of either AdIL-6 or AdOSM and LLC cells simultaneously was shown to increase tumor burden relative to AdDl70 co-administration. These results suggest a possible role of IL-6 or OSM in promoting lung tumor development in animal models and may ultimately reveal gp130 cytokines IL-6 or OSM as a possible therapeutic target for the treatment of lung cancer.</p> / Master of Science (MSc)
|
Page generated in 0.0384 seconds